Acquisitions5 Aug 2025, 09:41 pm
Orchid Pharma Wins Asset Purchase of Allecra Therapeutics SAS in France
AI Summary
Orchid Pharma Ltd. has announced that it has won the court order in France to acquire the assets of Allecra Therapeutics SAS. This decision comes after the initial intimation dated July 30, 2025, regarding the purchase of Allecra's assets. The Hon’ble Court of France has pronounced the order in favor of Orchid Pharma Limited, allowing the acquisition to take effect from August 01, 2025. Stakeholders are requested to take note of this update.
Key Highlights
- Orchid Pharma Ltd. has won the court order in France to acquire Allecra Therapeutics SAS's assets.
- The acquisition is set to take effect from August 01, 2025.
- This announcement follows the initial intimation dated July 30, 2025.
- The Hon’ble Court of France has pronounced the order in favor of Orchid Pharma Limited.